Pentwater Capital Management LP Poseida Therapeutics, Inc. Transaction History
Pentwater Capital Management LP
- $9.58 Billion
- Q3 2024
A detailed history of Pentwater Capital Management LP transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Pentwater Capital Management LP holds 5,975,000 shares of PSTX stock, worth $56.5 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
5,975,000
Previous 5,975,000
-0.0%
Holding current value
$56.5 Million
Previous $17.4 Million
2.06%
% of portfolio
0.18%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding PSTX
# of Institutions
98Shares Held
38.5MCall Options Held
377KPut Options Held
22.2K-
Black Rock Inc. New York, NY4.91MShares$46.4 Million0.0% of portfolio
-
Silverarc Capital Management, LLC3.69MShares$34.8 Million2.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.66MShares$34.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$20.7 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA2MShares$18.9 Million0.3% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $811M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...